Key facts
- This page summarizes Jiong Ma's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2025, 21:46.
Jiong Ma - 31 Mar 2025 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Reporting relationship
- Director
- Issuer ticker
- AVXL
- Reported as of
- 31 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2025, 21:46:45 UTC
- Prior SEC filing
- 01 Apr 2025
- Next SEC filing
- 20 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jiong Ma
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jiong Ma filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 01 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $8.58
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in three equal annual installments beginning on March 31, 2026